Preliminary trial results show ‘dramatic and rapid’ regression of glioblastoma after next generation CAR T-cell therapy
A phase 1 clinical trial evaluating a new approach to CAR-T therapy for glioblastoma (GBM) has shown dramatic results among the first patients to receive the novel treatment. …